WH Menopause/middle aged women's questions
1. The North American Menopause Society (NAMS) cur- b
rent position on the use of HT in menopausal women
include:
a. HT is indicated for the sole purpose of preventing
cardiovascular disease.
b. ET for less than 5 years has significant effect on the
risk for breast cancer.
c. HT is recommended for prevention of cognitive ag-
ing or dementia.
d. EPT is recommended to decrease risk of endometrial
carcinoma.
Ch 12
2. Use of vaginal estrogen for treatment of VVA in a F
woman w/an intact uterus requires co-administration
use of progesterone.
T/F
3. For the woman who has never experienced orgasm, d
the clinician should
a.explain that most women achieve orgasm only
through penetration if the vagina
b. suggest psychotherapy before suggesting any self
help measurea
c. rec'd Kegel exercises to help inhibit orgasm re-
sponse
d. diagram and describe female genital anatomy to
her
1/6
, WH Menopause/middle aged women's questions
Ch 16
4. There is insufficient data to support the method for T
discontinuing hormone therapy. Recurrence is similar
whether tapered or if cessation is abrupt
T/F
Ch 12
5. Modifiable risk factors for osteoporosis include all but c
the following
a. low estrogen level
b. lifestyle factors including smoking and excessive
ETOH
c. advanced age
d. lack of wt bearing exercises
Ch 12
6. What type(s) of estrogen are usually present in a a
woman's body in the postmenopausal years?
a. Estrone (E1) and estradiol (E2)
b. Estrone (E1) and estriol (E3)
c. Estradiol (E2) only
d. None; women do not produce estrogen after
menopause.
Ch 12
7. 1st line treatment to manage vaginal dryness and dys- b
pareunia symptoms in menopause include:
2/6
1. The North American Menopause Society (NAMS) cur- b
rent position on the use of HT in menopausal women
include:
a. HT is indicated for the sole purpose of preventing
cardiovascular disease.
b. ET for less than 5 years has significant effect on the
risk for breast cancer.
c. HT is recommended for prevention of cognitive ag-
ing or dementia.
d. EPT is recommended to decrease risk of endometrial
carcinoma.
Ch 12
2. Use of vaginal estrogen for treatment of VVA in a F
woman w/an intact uterus requires co-administration
use of progesterone.
T/F
3. For the woman who has never experienced orgasm, d
the clinician should
a.explain that most women achieve orgasm only
through penetration if the vagina
b. suggest psychotherapy before suggesting any self
help measurea
c. rec'd Kegel exercises to help inhibit orgasm re-
sponse
d. diagram and describe female genital anatomy to
her
1/6
, WH Menopause/middle aged women's questions
Ch 16
4. There is insufficient data to support the method for T
discontinuing hormone therapy. Recurrence is similar
whether tapered or if cessation is abrupt
T/F
Ch 12
5. Modifiable risk factors for osteoporosis include all but c
the following
a. low estrogen level
b. lifestyle factors including smoking and excessive
ETOH
c. advanced age
d. lack of wt bearing exercises
Ch 12
6. What type(s) of estrogen are usually present in a a
woman's body in the postmenopausal years?
a. Estrone (E1) and estradiol (E2)
b. Estrone (E1) and estriol (E3)
c. Estradiol (E2) only
d. None; women do not produce estrogen after
menopause.
Ch 12
7. 1st line treatment to manage vaginal dryness and dys- b
pareunia symptoms in menopause include:
2/6
